JP2019534299A - Process for producing (S) -N1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride - Google Patents
Process for producing (S) -N1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride Download PDFInfo
- Publication number
- JP2019534299A JP2019534299A JP2019523878A JP2019523878A JP2019534299A JP 2019534299 A JP2019534299 A JP 2019534299A JP 2019523878 A JP2019523878 A JP 2019523878A JP 2019523878 A JP2019523878 A JP 2019523878A JP 2019534299 A JP2019534299 A JP 2019534299A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- general formula
- solvent
- temperature
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 title claims abstract description 10
- GJOSEARIOFWCNW-UHFFFAOYSA-N Cl.Cl.Cl.CC(CN)N Chemical compound Cl.Cl.Cl.CC(CN)N GJOSEARIOFWCNW-UHFFFAOYSA-N 0.000 title claims abstract description 8
- 238000000034 method Methods 0.000 title claims description 29
- 150000001875 compounds Chemical class 0.000 claims description 51
- 239000000203 mixture Substances 0.000 claims description 34
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 24
- 239000002904 solvent Substances 0.000 claims description 23
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 22
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 20
- 238000006243 chemical reaction Methods 0.000 claims description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 11
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 9
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 8
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 6
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 6
- 125000004069 aziridinyl group Chemical group 0.000 claims description 6
- 125000006239 protecting group Chemical group 0.000 claims description 6
- 230000008878 coupling Effects 0.000 claims description 5
- 238000010168 coupling process Methods 0.000 claims description 5
- 238000005859 coupling reaction Methods 0.000 claims description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 238000007363 ring formation reaction Methods 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000002841 Lewis acid Substances 0.000 claims description 3
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 claims description 3
- 239000012346 acetyl chloride Substances 0.000 claims description 3
- 125000001246 bromo group Chemical group Br* 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 150000007517 lewis acids Chemical class 0.000 claims description 3
- 150000002902 organometallic compounds Chemical class 0.000 claims description 3
- 238000006467 substitution reaction Methods 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 claims description 2
- 150000001541 aziridines Chemical class 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 150000002736 metal compounds Chemical class 0.000 claims description 2
- 238000007142 ring opening reaction Methods 0.000 claims description 2
- MFPWEWYKQYMWRO-UHFFFAOYSA-N tert-butyl carboxy carbonate Chemical compound CC(C)(C)OC(=O)OC(O)=O MFPWEWYKQYMWRO-UHFFFAOYSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 12
- 239000000243 solution Substances 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- -1 4-ethoxybenzyl Chemical group 0.000 description 7
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 7
- 238000005160 1H NMR spectroscopy Methods 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- SLYTULCOCGSBBJ-UHFFFAOYSA-I disodium;2-[[2-[bis(carboxylatomethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+) Chemical compound [Na+].[Na+].[Gd+3].CCOC1=CC=C(CC(CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)N(CC([O-])=O)CC([O-])=O)C=C1 SLYTULCOCGSBBJ-UHFFFAOYSA-I 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 4
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001540 azides Chemical group 0.000 description 3
- 229940075342 gadoxetate disodium Drugs 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- JFEKJQFDERWHQN-SNVBAGLBSA-N (2R)-1-azido-3-(4-ethoxyphenyl)propan-2-ol Chemical compound N(=[N+]=[N-])C[C@@H](CC1=CC=C(C=C1)OCC)O JFEKJQFDERWHQN-SNVBAGLBSA-N 0.000 description 2
- CRCIASUNXSOPCW-SNVBAGLBSA-N (2R)-1-chloro-3-(4-ethoxyphenyl)propan-2-ol Chemical compound ClC[C@@H](CC1=CC=C(C=C1)OCC)O CRCIASUNXSOPCW-SNVBAGLBSA-N 0.000 description 2
- OFBDJBKDYABGSR-JNQXMBDASA-N (2s)-1-n-(2-aminoethyl)-3-(4-ethoxyphenyl)propane-1,2-diamine;trihydrochloride Chemical compound Cl.Cl.Cl.CCOC1=CC=C(C[C@H](N)CNCCN)C=C1 OFBDJBKDYABGSR-JNQXMBDASA-N 0.000 description 2
- WVUYYXUATWMVIT-UHFFFAOYSA-N 1-bromo-4-ethoxybenzene Chemical compound CCOC1=CC=C(Br)C=C1 WVUYYXUATWMVIT-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 150000004985 diamines Chemical class 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- BRLQWZUYTZBJKN-VKHMYHEASA-N (-)-Epichlorohydrin Chemical compound ClC[C@H]1CO1 BRLQWZUYTZBJKN-VKHMYHEASA-N 0.000 description 1
- QYIXEVDRZCBQCV-LBPRGKRZSA-N (2s)-1-n-(2-aminoethyl)-3-(4-ethoxyphenyl)propane-1,2-diamine Chemical compound CCOC1=CC=C(C[C@H](N)CNCCN)C=C1 QYIXEVDRZCBQCV-LBPRGKRZSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/04—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
- C07C209/22—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of other functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/20—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C219/22—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
- C07C247/08—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being unsaturated
- C07C247/10—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being unsaturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
- C07C41/30—Preparation of ethers by reactions not forming ether-oxygen bonds by increasing the number of carbon atoms, e.g. by oligomerisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本発明は、(S)-N1−(2-アミノエチル)-3-(4-アルコキシフェニル)プロパン-1,2-ジアミン三塩酸塩を製造する新規な方法に関する。The present invention relates to a novel process for preparing (S) -N1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride.
Description
本発明は、(S)-N1−(2-アミノエチル)-3-(4-アルコキシフェニル)プロパン-1,2-ジアミン三塩酸塩を製造する新規な方法に関する。 The present invention relates to a novel process for preparing (S) —N 1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride.
EOVIST(登録商標)は、磁気共鳴映像法(MRI)用の常磁性造影剤であって、血管、組織、及び他の非骨性組織のMRIに用いられ、特に肝組織の異常診断に有用である。EOVIST(登録商標)は、薬学的有効成分としてガドキセテート二ナトリウム(gadoxetate disodium)を含み、725.72の分子量、GdC23H28N3O11Na2の化学式、及びガドリニウム(4S)−4−(4-エトキシベンジル)-3,6,9-トリス(カルボキシラトメチル)−3,6,9−トリアザウンデカン酸二ナトリウム塩の構造式を有する。ガドキセテート二ナトリウムは、水溶液中で下記の一般式(a)の構造を有する。 EOVIST (registered trademark) is a paramagnetic contrast agent for magnetic resonance imaging (MRI) and is used for MRI of blood vessels, tissues, and other non-osseous tissues, and is particularly useful for diagnosing abnormalities in liver tissues. is there. EOVIST® contains gadoxetate disodium as a pharmaceutically active ingredient, has a molecular weight of 725.72, a chemical formula of GdC 23 H 28 N 3 O 11 Na 2 , and gadolinium (4S) -4- ( It has the structural formula of 4-ethoxybenzyl) -3,6,9-tris (carboxylatomethyl) -3,6,9-triazaundecanoic acid disodium salt. Gadoxetate disodium has the structure of the following general formula (a) in an aqueous solution.
一般式(a)の化合物を合成するために(S)−N1−(2-アミノエチル)−3−(4−エトキシフェニル)プロパン−1,2−ジアミンから中間体である(S)−2,2' −(2−((2-(ビス(カルボキシメチル)アミノ)−3−(4−エトキシフェニル)プロピル)カルボキシメチル)アミノ)エチルアザンジイル)二酢酸を合成する方法は、中国特許出願CN104761461に開示されている。しかし、市販の化合物である4−ブロモフェネトールから反応物として用いられる(S)−N1−(2-アミノエチル)−3−(4−エトキシフェニル)プロパン−1,2−ジアミン三塩酸塩を製造する方法を開示する文献はない。 In order to synthesize the compound of the general formula (a), (S) -N 1- (2-aminoethyl) -3- (4-ethoxyphenyl) propane-1,2-diamine is an intermediate. 2,2 ′-(2-((2- (bis (carboxymethyl) amino) -3- (4-ethoxyphenyl) propyl) carboxymethyl) amino) ethylazanediyl) diacetic acid is a Chinese patent. It is disclosed in application CN104761461. However, (S) —N 1- (2-aminoethyl) -3- (4-ethoxyphenyl) propane-1,2-diamine trihydrochloride used as a reactant from the commercially available compound 4-bromophenetole There is no literature which discloses the method of manufacturing.
本発明者らは、ガドキセテート二ナトリウム製造に用いることができる中間体として、(S)−N1−(2-アミノエチル)−3−(4−アルコキシフェニル)プロパン−1,2−ジアミン三塩酸塩を提供する方法を見出すために長い間研究を行い、その結果、1−ハロ−4−エトキシベンゼンからのグリニャールカップリングを含む一連のプロセスが(S)−N1−(2-アミノエチル)−3−(4−アルコキシフェニル)プロパン−1,2−ジアミン三塩酸塩の効率的な大量生産を可能にする経済的で簡単な方法であることを確認し、本発明を完成した。 As intermediates that can be used in the production of gadoxetate disodium, the present inventors have (S) -N 1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride. Long-term studies have been carried out to find ways to provide salts, and as a result, a series of processes involving Grignard coupling from 1-halo-4-ethoxybenzene has been performed (S) -N 1- (2-aminoethyl) It was confirmed that this was an economical and simple method enabling efficient mass production of -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride, and the present invention was completed.
前記目的を達成するために、本発明の例示的な実施形態は以下の段階を含む(S)−N1−(2-アミノエチル)−3−(4−アルコキシフェニル)プロパン−1,2−ジアミン三塩酸塩を製造するための方法を提供する:
(1)一般式(1)の化合物のグリニャールカップリングによって一般式(2)の化合物を製造する段階;(2)アジ化ナトリウムとの反応において、一般式(2)の化合物をアジド置換によって一般式(3)の化合物を製造する段階;(3)トリフェニルホスフィンを用いて一般式(3)の化合物を環化によって保護されたアミノ基を有する一般式(4)のアジリジン誘導体を製造する段階;(4)一般式(4)の化合物を開環することによって一般式(5)の化合物を製造する段階;及び(5)一般式(5)の化合物のアミノ保護基を除去するための反応によって一般式(6)の化合物を製造する段階:
RはC1-6アルキルである。)。
To achieve the above object, an exemplary embodiment of the present invention includes (S) -N 1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-, which comprises the following steps: A method for producing diamine trihydrochloride is provided:
(1) A step of producing a compound of the general formula (2) by Grignard coupling of a compound of the general formula (1); (2) In the reaction with sodium azide, the compound of the general formula (2) is generally substituted by azide substitution. A step of producing a compound of formula (3); (3) a step of producing an aziridine derivative of general formula (4) having an amino group protected by cyclization of the compound of general formula (3) with triphenylphosphine. (4) a step of producing a compound of the general formula (5) by opening the compound of the general formula (4); and (5) a reaction for removing the amino protecting group of the compound of the general formula (5) Preparing the compound of general formula (6) by:
R is C 1-6 alkyl. ).
例えば、Xはブロモであってもよい。 For example, X may be bromo.
例えば、Rはエチルであってもよい。 For example, R may be ethyl.
従来、(S)−N1−(2-アミノエチル)−3−(4−アルコキシフェニル)プロパン−1,2−ジアミン三塩酸塩の製造方法は、水酸基を含む化合物を用いて、さらにアルコキシ、 例えば、エトキシを導入する段階を含むことによって行われていて、また、不必要な官能基を除去するためにPd/Cを用いてさらなる水素化を必要とするなどの不都合があった。したがって、本発明は商業的に入手可能であり、そのような不要なプロセスを最小限に抑えた簡便に利用できる簡単な化合物を用いて(S)−N1−(2-アミノエチル)−3−(4−アルコキシフェニル)プロパン−1,2−ジアミン三塩酸塩の製造方法を合理化することを技術的な特徴とする。 Conventionally, a method for producing (S) —N 1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride uses a compound containing a hydroxyl group, further alkoxy, For example, it was carried out by including a step of introducing ethoxy, and there was a disadvantage that further hydrogenation was required using Pd / C to remove unnecessary functional groups. Thus, the present invention is commercially available and using (S) -N 1- (2-aminoethyl) -3 with a simple compound that is readily available with minimal such unnecessary processes. It is technically characterized to streamline the process for producing-(4-alkoxyphenyl) propane-1,2-diamine trihydrochloride.
具体的には、段階(1)はグリニャールカップリングにより行うことができる。例えば、段階(1)は、一般式(1)の化合物を金属または有機金属化合物と反応させることによってグリニャール化合物を製造する段階(1-1);及び一般式(7)の化合物とグリニャール化合物を反応させる段階(1-2)によって行うことができる:
段階(1-1)の金属または有機金属化合物は、グリニャール化合物として製造することができる当該分野で公知の任意の物質であってもよいが、これに限定されない。例えば、前記化合物はマグネシウムであってもよいが、これに限定されない。 The metal or organometallic compound in step (1-1) may be any substance known in the art that can be produced as a Grignard compound, but is not limited thereto. For example, the compound may be magnesium, but is not limited thereto.
段階(1)の溶媒は、限定されず、グリニャールカップリングに一般的に用いられる任意の有機溶媒であってもよい。例えば、前記溶媒はテトラヒドロフラン(THF)、1,4-ジオキサン、ジエチルエーテル、またはそれらの混合物であってもよく、具体的には、テトラヒドロフラン(THF)であってもよいが、これに限定されない。 The solvent in step (1) is not limited and may be any organic solvent generally used for Grignard coupling. For example, the solvent may be tetrahydrofuran (THF), 1,4-dioxane, diethyl ether, or a mixture thereof, specifically tetrahydrofuran (THF), but is not limited thereto.
具体的には、段階(1-1)は、20℃〜60℃の温度で行われてもよい。段階(1-1)は、ハロゲン化合物と金属とを反応させてグリニャール化合物を製造する段階であり、前記段階を高温で行うと望ましくない副反応を引き起こす可能性がある。したがって、20℃〜30℃の低温で反応物をゆっくりと添加した後に、反応のために温度を上げてもよいが、温度を調整する方法はこれに限定されない。 Specifically, the step (1-1) may be performed at a temperature of 20 ° C. to 60 ° C. Step (1-1) is a step of producing a Grignard compound by reacting a halogen compound and a metal. If the step is performed at a high temperature, an undesirable side reaction may be caused. Therefore, after slowly adding the reactants at a low temperature of 20 ° C. to 30 ° C., the temperature may be increased for the reaction, but the method of adjusting the temperature is not limited thereto.
また、段階(1-2)は−20℃〜30℃、具体的には0℃〜20℃の温度で行ってもよいが、これに限定されない。(1-2)で用いられる反応物は反応性が高く、そのため、低温で反応を行うことが望ましい。例えば、−5℃の低い温度で反応物を添加すると、望ましくない方向への反応を妨げられることができる。 Further, the step (1-2) may be performed at a temperature of -20 ° C to 30 ° C, specifically 0 ° C to 20 ° C, but is not limited thereto. The reactant used in (1-2) has high reactivity, and therefore it is desirable to perform the reaction at a low temperature. For example, adding the reactant at a low temperature of −5 ° C. can prevent the reaction in an undesirable direction.
段階(1-2)は、触媒としてルイス酸をさらに含むことにより行われてもよい。ルイス酸の具体例としては、CuBrS(CH3)2、CuI及びCuCl2などが挙げられ、具体的には、CuIであってもよいが、これに限定されない。 Step (1-2) may be performed by further including a Lewis acid as a catalyst. Specific examples of the Lewis acid include CuBrS (CH 3 ) 2 , CuI, and CuCl 2. Specifically, CuI may be used, but is not limited thereto.
段階(1)の後に、製造された化合物を単離、精製、及び濃縮する少なくとも1つの段階をさらに行ってもよいが、これに限定されない。例えば、例示的な実施形態によれば、段階(1)の製造された化合物を有機溶媒を用いて抽出し、得られた有機層をEDTA水溶液及び20%塩化ナトリウム水溶液を使用して洗浄して、続いて硫酸ナトリウムで乾燥し、濾過した。前記ろ液を濃縮して生成された化合物を得た。 Step (1) may be further followed by at least one step of isolating, purifying, and concentrating the produced compound, but is not limited thereto. For example, according to an exemplary embodiment, the prepared compound of step (1) is extracted using an organic solvent, and the resulting organic layer is washed using an aqueous EDTA solution and a 20% aqueous sodium chloride solution. Followed by drying over sodium sulfate and filtration. The filtrate was concentrated to obtain the produced compound.
本発明の製造方法において、段階(2)は、段階(1)で得られたハロゲン、例えば、クロロを含む化合物のクロロ基をアジドに置換して行われてもよい。 In the production method of the present invention, step (2) may be carried out by substituting the chloro group of the halogen-containing compound obtained in step (1), such as chloro, with an azide.
段階(2)の溶媒は、限定されず、アジド置換において一般的に用いられる任意の有機溶媒であってもよい。例えば、前記溶媒はジメチルホルムアミドであってもよいが、これに限定されない。 The solvent of step (2) is not limited and may be any organic solvent commonly used in azide substitution. For example, the solvent may be dimethylformamide, but is not limited thereto.
一方、段階(2)は、70℃〜100℃の温度、例えば、80℃〜90℃または80℃〜85℃で行われてもよいが、これに限定されない。 Meanwhile, step (2) may be performed at a temperature of 70 ° C. to 100 ° C., for example, 80 ° C. to 90 ° C. or 80 ° C. to 85 ° C., but is not limited thereto.
段階(2)の後に、製造された化合物を単離、精製、及び濃縮する少なくとも1つの段階をさらに行ってもよいが、これに限定されない。例えば、例示的な実施形態によれば、段階(2)の製造された化合物を有機溶媒を使用して抽出し、得られた有機層は塩酸水溶液、5%重炭酸ナトリウム水溶液、及び10%塩化ナトリウム水溶液を用いて洗浄し、続いて硫酸ナトリウムで乾燥させ、濾過した。前記ろ液を濃縮して生成された化合物を得た。 After step (2), at least one step of isolating, purifying, and concentrating the prepared compound may be further performed, but is not limited thereto. For example, according to an exemplary embodiment, the compound produced in step (2) is extracted using an organic solvent, and the resulting organic layer is extracted with aqueous hydrochloric acid, 5% aqueous sodium bicarbonate, and 10% chloride. Wash with aqueous sodium followed by drying over sodium sulfate and filtering. The filtrate was concentrated to obtain the produced compound.
具体的に、段階(3)は、トリフェニルホスフィンによる環化によって一般式(3-1)のアジリジニル基を形成する段階(3-1);及び段階(3-1)で得られたアジリジニル基を含む化合物とジ−tert-ブチルジカーボネートとを反応させることによってアミノ基に保護基を導入する段階(3-2)により行うことができる。 Specifically, the step (3) includes the step (3-1) of forming an aziridinyl group of the general formula (3-1) by cyclization with triphenylphosphine; and the aziridinyl group obtained in the step (3-1). Can be carried out by the step (3-2) of introducing a protecting group into an amino group by reacting a compound containing bis and di-tert-butyl dicarbonate.
例えば、Rはエチルであってもよい。 For example, R may be ethyl.
すなわち、一般式(3)の化合物のヒドロキシ基及びアジド基を縮合してアミノ基を含む環構造であるアジリジニル基を形成した後、前記アジリジニル基のアミノ基にtert−ブチル保護基を導入してもよい。 That is, after the hydroxy group and the azide group of the compound of the general formula (3) are condensed to form an aziridinyl group that is a ring structure containing an amino group, a tert-butyl protecting group is introduced into the amino group of the aziridinyl group. Also good.
段階(3-2)は、4−ジメチルアミノピリジン及びヨウ素(I2)のような触媒、またはトリエタノールアミド(TEA)、N,N−ジイソプロピルエチルアミン(DIEA)、及びNaHCO3のようなアルカリ性物質をさらに含むことによって行われてもよいが、これに限定されない。 Step (3-2) is a catalyst such as 4-dimethylaminopyridine and iodine (I 2 ) or an alkaline substance such as triethanolamide (TEA), N, N-diisopropylethylamine (DIEA), and NaHCO 3. However, the present invention is not limited to this.
例えば、段階(3)は、溶媒としてアセトニトリル、トルエン、またはそれらの混合物を用いて行われてもよい。具体的に、溶媒はアセトニトリルであってもよいが、これに限定されない。 For example, step (3) may be performed using acetonitrile, toluene, or a mixture thereof as a solvent. Specifically, the solvent may be acetonitrile, but is not limited thereto.
また、段階(3-1)は、55℃〜70℃の温度、具体的には60℃〜65℃で行われてもよいが、これに限定されない。 In addition, the step (3-1) may be performed at a temperature of 55 ° C. to 70 ° C., specifically 60 ° C. to 65 ° C., but is not limited thereto.
また、段階(3−2)は、20℃〜30℃の温度、具体的には20℃〜25℃で行われてもよいが、これに限定されない。 The step (3-2) may be performed at a temperature of 20 ° C. to 30 ° C., specifically, 20 ° C. to 25 ° C., but is not limited thereto.
段階(4)の開環は、アセトニトリル、テトラヒドロフラン、トルエン、またはそれらの混合物を溶媒として用いて行われてもよい。具体的には、前記溶媒はアセトニトリルであってもよいが、これに限定されない。 Ring opening in step (4) may be performed using acetonitrile, tetrahydrofuran, toluene, or a mixture thereof as a solvent. Specifically, the solvent may be acetonitrile, but is not limited thereto.
また、段階(4)は、45℃〜55℃の温度、具体的には、50℃〜52℃で行われてもよいが、これに限定されない。 Further, step (4) may be performed at a temperature of 45 ° C. to 55 ° C., specifically, 50 ° C. to 52 ° C., but is not limited thereto.
一方、アミノ保護基を除去する段階(5)は、トリフルオロ酢酸、塩酸、メタノール性塩酸、またはそれらの混合物を用いて行われてもよい。具体的には、メタノール性塩酸が用いられてもよいが、これに限定されない。 On the other hand, the step (5) of removing the amino protecting group may be performed using trifluoroacetic acid, hydrochloric acid, methanolic hydrochloric acid, or a mixture thereof. Specifically, methanolic hydrochloric acid may be used, but is not limited thereto.
段階(5)は、溶媒として、メタノール、ジクロロメタン、テトラヒドロフラン、またはそれらの混合物、具体的にはメタノールを用いて行われてもよい。 Step (5) may be performed using methanol, dichloromethane, tetrahydrofuran, or a mixture thereof, specifically methanol, as a solvent.
一方、段階(5)で、メタノール性塩酸は、メタノール溶媒に塩化アセチルを混合することによって提供されてもよいが、これに限定されない。 Meanwhile, in step (5), the methanolic hydrochloric acid may be provided by mixing acetyl chloride with a methanol solvent, but is not limited thereto.
また、段階(5)は、45℃〜55℃の温度、具体的には、50℃〜52℃で行われてもよいが、これに限定されない。 Further, step (5) may be performed at a temperature of 45 ° C. to 55 ° C., specifically 50 ° C. to 52 ° C., but is not limited thereto.
さらに、段階(4)及び(5)が独立して完了された後に、段階(4)及び(5)は、製造された化合物を結晶化するための、それぞれの段階(4-1)または(5-1)のいずれか、または両方の段階をさらに含んでもよい。 Further, after steps (4) and (5) are completed independently, steps (4) and (5) are used to crystallize the produced compound in the respective steps (4-1) or ( Either or both of the steps of 5-1) may be further included.
例えば、段階(4-1)は、エタノール、酢酸エチル、またはそれらの混合物を溶媒として用いて行ってもよい。具体的には、一般式(5)の化合物はエタノールと酢酸エチルとの混合物を溶媒として用いて結晶化させてもよいが、これに限定されない。 For example, step (4-1) may be performed using ethanol, ethyl acetate, or a mixture thereof as a solvent. Specifically, the compound of the general formula (5) may be crystallized using a mixture of ethanol and ethyl acetate as a solvent, but is not limited thereto.
一方、段階(5-1)は、メタノール、アセトン、メチルtert−ブチルエーテル、またはそれらの混合物を溶媒として用いて行われてもよい。具体的には、一般式(6)の化合物はメチルtert−ブチルエーテルを溶媒として用いて結晶化させてもよいが、これに限定されない。 Meanwhile, step (5-1) may be performed using methanol, acetone, methyl tert-butyl ether, or a mixture thereof as a solvent. Specifically, the compound of the general formula (6) may be crystallized using methyl tert-butyl ether as a solvent, but is not limited thereto.
本発明の製造方法は、合理的な価格の原料及び簡単な反応プロセスを用いることで(S)−N1−(2-アミノエチル)−3−(4−アルコキシフェニル)プロパン−1,2−ジアミン三塩酸塩の効率的かつ経済的な製造を可能にし、またその商業的大量生産に有用に適用することができる。 The production method of the present invention uses (S) -N 1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2- by using a reasonably priced raw material and a simple reaction process. It enables efficient and economical production of diamine trihydrochloride and can be usefully applied to its commercial mass production.
以下、本発明は添付した図面を参照して詳細に説明する。しかしながら、本明細書に開示された例示的な実施形態は例示目的のためだけのものであり、本発明の範囲を限定するものとして解釈されるべきではない。 Hereinafter, the present invention will be described in detail with reference to the accompanying drawings. However, the exemplary embodiments disclosed herein are for illustrative purposes only and should not be construed as limiting the scope of the invention.
以下、具体的な開示のない試料及び溶媒は、Sigma - Aldrich Koreaから購入し、1H−NMR分光法は、Bruker 400MHz NMR分光計を用いて実施した。 Hereinafter, samples and solvents without specific disclosure were purchased from Sigma-Aldrich Korea, and 1 H-NMR spectroscopy was performed using a Bruker 400 MHz NMR spectrometer.
以下の反応式に従って、実施例1〜5を行った。 Examples 1 to 5 were performed according to the following reaction formula.
実施例1:(R)−1−クロロ−3−(4−エトキシフェニル)プロパン−2−オールの製造
窒素雰囲気で置換した反応器中で、マグネシウム(14.50g、596.84mmol)を600mLのTHFに加え、混合物を撹拌して溶解させた。温度を20℃〜30℃に保ちながら、4−ブロモフェネトール(120.0g、596.84mmol)をゆっくり加えた。滴下終了後、温度を60℃に上げ、混合物を2時間攪拌してから−5℃に冷却し、続いてヨウ化銅(0.76g、2.98mmol)を加えて混合物をさらに30分間攪拌した。その後、(R)−エピクロロヒドリン(49.70g、537.15mmol)をゆっくり加え、混合物を室温で1時間撹拌した。反応終了後、5℃に温度を下げ、塩酸水溶液(3M、600mL)及びイソプロピルエーテル(360mL)を添加して層に分離した。有機層を10%EDTA水溶液(480mL)及び20%塩化ナトリウム水溶液(240mL)で2回洗浄し、硫酸ナトリウムで乾燥し、混合物をろ過した。ろ液を濃縮して表題化合物である(R)−1−クロロ−3−(4−エトキシフェニル)プロパン−2−オール(123.2g、収率100%)を収得した。
Example 1: Preparation of (R) -1-chloro-3- (4-ethoxyphenyl) propan-2-ol In a reactor purged with nitrogen atmosphere, magnesium (14.50 g, 596.84 mmol) was added to 600 mL. In addition to THF, the mixture was stirred to dissolve. 4-Bromophenetole (120.0 g, 596.84 mmol) was slowly added while maintaining the temperature at 20-30 ° C. After the addition was complete, the temperature was raised to 60 ° C. and the mixture was stirred for 2 hours and then cooled to −5 ° C., followed by addition of copper iodide (0.76 g, 2.98 mmol) and the mixture was stirred for an additional 30 minutes. . (R) -epichlorohydrin (49.70 g, 537.15 mmol) was then added slowly and the mixture was stirred at room temperature for 1 hour. After completion of the reaction, the temperature was lowered to 5 ° C., and aqueous hydrochloric acid (3M, 600 mL) and isopropyl ether (360 mL) were added to separate the layers. The organic layer was washed twice with 10% aqueous EDTA solution (480 mL) and 20% aqueous sodium chloride solution (240 mL), dried over sodium sulfate, and the mixture was filtered. The filtrate was concentrated to obtain the title compound (R) -1-chloro-3- (4-ethoxyphenyl) propan-2-ol (123.2 g, yield 100%).
1H−NMR(CDCl3、400MHz):δ(ppm)1.41(t、3H)、2.17(d、1H)、2.83(d、2H)、3.49〜3.61(m、2H)、4.00〜4.04(m、3H)、6.85(d、2H)、7.14(d、2H)。 1 H-NMR (CDCl 3 , 400 MHz): δ (ppm) 1.41 (t, 3H), 2.17 (d, 1H), 2.83 (d, 2H), 3.49 to 3.61 ( m, 2H), 4.00 to 4.04 (m, 3H), 6.85 (d, 2H), 7.14 (d, 2H).
実施例2:(R)−1−アジド−3−(4−エトキシフェニル)プロパン−2−オールの製造
実施例1で製造した(R)−1−クロロ−3−(4−エトキシフェニル)プロパン−2−オール(115.33g、537.15mmol)をジメチルホルムアミド580mLに加え、混合物を撹拌して溶解させた。その後、ヨウ化ナトリウム(8.05g、53.72mmol)とアジ化ナトリウム(69.85g、1074.39mmol)とをこれに添加した。反応器内の温度を85℃に上げ、16時間攪拌した。反応終了後、混合物を室温まで冷却し、精製水580mL及びイソプロピルエーテル580mLを添加して層に分離した。その後、前記得られた水層をさらにイソプロピルエーテル(190mL)で2回抽出した。回収した有機層を塩酸水溶液(1M、580mL)、5%炭酸水素ナトリウム水溶液(580mL)、及び10%塩化ナトリウム水溶液(580mL)で洗浄し、硫酸ナトリウムで乾燥し、混合物を濾過した。ろ液を濃縮して表題化合物である(R)−1−アジド−3−(4−エトキシフェニル)プロパン−2−オール(113.5g、収率95.5%)を収得した。
Example 2: Production of (R) -1-azido-3- (4-ethoxyphenyl) propan-2-ol (R) -1-chloro-3- (4-ethoxyphenyl) propane produced in Example 1 2-ol (115.33 g, 537.15 mmol) was added to 580 mL of dimethylformamide and the mixture was stirred to dissolve. Then sodium iodide (8.05 g, 53.72 mmol) and sodium azide (69.85 g, 107.39 mmol) were added thereto. The temperature in the reactor was raised to 85 ° C. and stirred for 16 hours. After completion of the reaction, the mixture was cooled to room temperature, and purified water (580 mL) and isopropyl ether (580 mL) were added to separate the layers. Thereafter, the obtained aqueous layer was further extracted twice with isopropyl ether (190 mL). The collected organic layer was washed with aqueous hydrochloric acid solution (1M, 580 mL), 5% aqueous sodium hydrogen carbonate solution (580 mL), and 10% aqueous sodium chloride solution (580 mL), dried over sodium sulfate, and the mixture was filtered. The filtrate was concentrated to obtain the title compound (R) -1-azido-3- (4-ethoxyphenyl) propan-2-ol (113.5 g, yield 95.5%).
1H - NMR(CDCl3、400MHz):δ(ppm)1.41(t、3H)、1.97(d、1H)、2.71−2.79(m、2H)、3.28(dd、1H)、3.38(dd、1H) 、3.94−4.01(m、1H)、4.04(q、2H)、6.86(d、2H)、7.10(d、2H)。 1 H-NMR (CDCl 3 , 400 MHz): δ (ppm) 1.41 (t, 3H), 1.97 (d, 1H), 2.71-2.79 (m, 2H), 3.28 ( dd, 1H), 3.38 (dd, 1H), 3.94-4.01 (m, 1H), 4.04 (q, 2H), 6.86 (d, 2H), 7.10 (d 2H).
実施例3:(S)−tert−ブチル2−(4−エトキシベンジル)アジリジン−1−カルボキシレートの製造
窒素雰囲気に置換した反応器中で、実施例2で製造した(R)−1−アジド−3−(4−エトキシフェニル)プロパン−2−オール(113.0g、510.71mmol)をアセトニトリル(AN、1130mL)に加え、混合物を撹拌し、続いてトリフェニルホスフィン(PPh3、120.56g、459.64mmol)を加えて室温で2時間撹拌し、4時間還流した。反応完了後、混合物を20℃に冷却し、4−ジメチルアミノピリジン(DMAP、0.62g、122.17mmol)及びジ−tert−ブチルジカーボネート((Boc)2O、100.32g、459.64mmol)をゆっくり加え、混合物を30分間撹拌した。前記混合物に過酸化水素(11.60g、102.14mmol)を加えて、さらに30分間撹拌した後、生成物を濃縮し、アセトニトリルを除去した。得られた濃縮物にヘプタン(1130mL)を入れ、20℃〜25℃で30分間攪拌した後、前記生成物をろ過した。ろ液を濃縮して表題化合物である(S)−tert−ブチル2−(4−エトキシベンジル)アジリジン−1−カルボキシレート(113.05g、収率93.9%)を収得した。
Example 3: Preparation of (S) -tert-butyl 2- (4-ethoxybenzyl) aziridine-1-carboxylate (R) -1-Azide prepared in Example 2 in a reactor purged with nitrogen atmosphere -3- (4-Ethoxyphenyl) propan-2-ol (113.0 g, 510.71 mmol) was added to acetonitrile (AN, 1130 mL) and the mixture was stirred, followed by triphenylphosphine (PPh 3 , 120.56 g). 459.64 mmol) was added and stirred at room temperature for 2 hours and refluxed for 4 hours. After completion of the reaction, the mixture was cooled to 20 ° C. and 4-dimethylaminopyridine (DMAP, 0.62 g, 122.17 mmol) and di-tert-butyl dicarbonate ((Boc) 2 O, 100.32 g, 458.64 mmol). ) Was added slowly and the mixture was stirred for 30 minutes. Hydrogen peroxide (11.60 g, 102.14 mmol) was added to the mixture and stirred for an additional 30 minutes before the product was concentrated to remove acetonitrile. Heptane (1130 mL) was added to the resulting concentrate and stirred at 20 ° C. to 25 ° C. for 30 minutes, and then the product was filtered. The filtrate was concentrated to obtain the title compound (S) -tert-butyl 2- (4-ethoxybenzyl) aziridine-1-carboxylate (113.05 g, yield 93.9%).
1H - NMR(CDCl3、400MHz):δ(ppm)1.39−1.45(m、12H)、2.01(d、1H)、2.29(d、1H)、2.57−2.62(m、2H)、2.91(q、 1H)、4.02(q、2H)、6.84(d、2H)、7.20(d、2H)。 1 H-NMR (CDCl 3 , 400 MHz): δ (ppm) 1.39-1.45 (m, 12H), 2.01 (d, 1H), 2.29 (d, 1H), 2.57- 2.62 (m, 2H), 2.91 (q, 1H), 4.02 (q, 2H), 6.84 (d, 2H), 7.20 (d, 2H).
実施例4:(S)−tert−ブチル1−(2−アミノエチルアミノ)−3−(4−エトキシフェニル)プロパン−2−イルカルバメート二塩酸塩の製造
実施例3で製造した(S)−tert−ブチル2−(4−エトキシベンジル)アジリジン−1−カルボキシレート(133.05g、479.70mmol)をアセトニトリル(400mL)に加えて、混合物を攪拌して溶解させた後、エチレンジアミン(432.45g、7195.52mmol)を加え、50℃で6時間撹拌した。反応終了後、生成物を濃縮し、内部温度を5℃に下げて、塩酸水溶液(2M、480mL)及び酢酸エチル(266mL)を添加して層に分離した。水層に50%水酸化ナトリウム水溶液(200mL)を加え、混合物を酢酸エチル(530mL)で分離した。有機層を20%塩化ナトリウム(266mL)で洗浄し、硫酸ナトリウムで乾燥して、混合物を濾過した。ろ液を50℃で真空乾燥して表題化合物である(S)−tert−ブチル1−(2−アミノエチルアミノ)−3−(4−エトキシフェニル)プロパン−2−イルカルバメート二塩酸塩(135.5g、収率68.8% )を収得した。
Example 4: Preparation of (S) -tert-butyl 1- (2-aminoethylamino) -3- (4-ethoxyphenyl) propan-2-ylcarbamate dihydrochloride (S)-prepared in Example 3 tert-Butyl 2- (4-ethoxybenzyl) aziridine-1-carboxylate (133.05 g, 479.70 mmol) was added to acetonitrile (400 mL) and the mixture was stirred to dissolve, followed by ethylenediamine (432.45 g , 7195.52 mmol), and the mixture was stirred at 50 ° C. for 6 hours. After completion of the reaction, the product was concentrated, the internal temperature was lowered to 5 ° C., aqueous hydrochloric acid (2M, 480 mL) and ethyl acetate (266 mL) were added and the layers were separated. To the aqueous layer was added 50% aqueous sodium hydroxide solution (200 mL), and the mixture was separated with ethyl acetate (530 mL). The organic layer was washed with 20% sodium chloride (266 mL), dried over sodium sulfate and the mixture was filtered. The filtrate was dried in vacuo at 50 ° C. and the title compound (S) -tert-butyl 1- (2-aminoethylamino) -3- (4-ethoxyphenyl) propan-2-ylcarbamate dihydrochloride (135 0.5 g, yield 68.8%).
1H−NMR(D2O、400MHz):δ(ppm)1.02(s、2H)、1.14(s、9H)、1.24(t、3H)、2.46(dd、1H)、2.82(dd、1H)、3.07(t、1H)、3.25−3.39(m、6H)、3.94−4.00(m、3H)、6.83(d、2H)、7.10(d、2H)。 1 H-NMR (D 2 O, 400 MHz): δ (ppm) 1.02 (s, 2H), 1.14 (s, 9H), 1.24 (t, 3H), 2.46 (dd, 1H ), 2.82 (dd, 1H), 3.07 (t, 1H), 3.25-3.39 (m, 6H), 3.94-4.00 (m, 3H), 6.83 ( d, 2H), 7.10 (d, 2H).
実施例5:(S)−N1−(2−アミノエチル)−3−(4−エトキシフェニル)プロパン−1,2−ジアミン三塩酸塩の製造
反応器に、メタノール(950mL)及び塩化アセチル(77.75g、990.55mmol)を加え、混合物を撹拌して溶解させた。この溶液に、実施例4で製造した(S)−tert−ブチル1−(2−アミノエチルアミノ)−3−(4−エトキシフェニル)プロパン−2−イルカルバメート二塩酸塩(135.5g、330.18mmol)を加え、混合物を50℃で1時間撹拌した。反応終了後、メチルtert−ブチルエーテル(950mL)を加え、混合物を結晶化して濾過した。 得られた結晶を50℃で真空乾燥して表題化合物である(S)−N1−(2−アミノエチル)−3−(4−エトキシフェニル)プロパン−1,2−ジアミン三塩酸塩 (105.2g、収率99.8%)を収得した。
Example 5: Preparation of (S) -N 1- (2-aminoethyl) -3- (4-ethoxyphenyl) propane-1,2-diamine trihydrochloride A reactor was charged with methanol (950 mL) and acetyl chloride ( 77.75 g, 990.55 mmol) was added and the mixture was stirred to dissolve. To this solution was added (S) -tert-butyl 1- (2-aminoethylamino) -3- (4-ethoxyphenyl) propan-2-ylcarbamate dihydrochloride (135.5 g, 330) prepared in Example 4. .18 mmol) was added and the mixture was stirred at 50 ° C. for 1 h. After completion of the reaction, methyl tert-butyl ether (950 mL) was added, and the mixture was crystallized and filtered. The obtained crystals were vacuum-dried at 50 ° C. and the title compound (S) —N 1- (2-aminoethyl) -3- (4-ethoxyphenyl) propane-1,2-diamine trihydrochloride (105 .2 g, yield 99.8%).
1H−NMR(D2O、400MHz):δ(ppm)1.38(t、3H)、3.00(dd、1H)、3.17(dd、1H)、3.43〜3.58(m、6H)、3.94〜4.01(m、 1H)、4.13(q、2H)、7.03(d、2H)、7.31(d、2H)。
1 H-NMR (D 2 O, 400 MHz): δ (ppm) 1.38 (t, 3H), 3.00 (dd, 1H), 3.17 (dd, 1H), 3.43 to 3.58 (M, 6H), 3.94 to 4.01 (m, 1H), 4.13 (q, 2H), 7.03 (d, 2H), 7.31 (d, 2H).
Claims (21)
(1)一般式(1)の化合物のグリニャールカップリングによって一般式(2)の化合物を製造する段階;
(2)アジ化ナトリウムとの反応において、一般式(2)の化合物をアジド置換によって一般式(3)の化合物を製造する段階;
(3)トリフェニルホスフィンを用いて一般式(3)の化合物を環化によってアミノ保護基により保護されたアミノ基を有する一般式(4)のアジリジン誘導体を製造する段階;
(4)一般式(4)の化合物を開環することによって一般式(5)の化合物を製造する段階;及び
(5)一般式(5)の化合物のアミノ保護基を除去するための反応によって一般式(6)の化合物を製造する段階:
(1) producing a compound of general formula (2) by Grignard coupling of the compound of general formula (1);
(2) a step of producing a compound of the general formula (3) by azide substitution of the compound of the general formula (2) in the reaction with sodium azide;
(3) A step of producing an aziridine derivative of the general formula (4) having an amino group protected by an amino protecting group by cyclization of the compound of the general formula (3) with triphenylphosphine;
(4) producing a compound of general formula (5) by ring-opening the compound of general formula (4); and (5) by a reaction to remove the amino protecting group of the compound of general formula (5). Step for producing a compound of the general formula (6):
(1-1)一般式(1)の化合物と金属または有機金属化合物とを反応させてグリニャール化合物を製造する段階;及び
(1-2)前記グリニャール化合物と一般式(7)の化合物とを反応させる段階:
(1-1) reacting a compound of general formula (1) with a metal or organometallic compound to produce a Grignard compound; and (1-2) reacting the Grignard compound with a compound of general formula (7). Stage to make:
(3-1)トリフェニルホスフィンによる環化によって一般式(3-1)のアジリジニル基を形成する段階;及び
(3-2)段階(3-1)により得られるアジリジニル基を含む化合物とジ-tert-ブチルジカーボネートとを反応させることによってアミノ基に保護基を導入する段階:
を含む、請求項1に記載の方法。 Stage (3) is the following stage:
(3-1) a step of forming an aziridinyl group of the general formula (3-1) by cyclization with triphenylphosphine; and (3-2) a compound containing an aziridinyl group obtained by the step (3-1) and di- introducing a protecting group into the amino group by reacting with tert-butyl dicarbonate:
The method of claim 1 comprising:
Step (4-1) is performed using ethanol, ethyl acetate, or a mixture thereof as a solvent, and Step (5-1) is performed using methanol, acetone, methyl tert-butyl ether, or a mixture thereof as a solvent. 21. The method of claim 20, wherein the method is carried out using.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2016-0146850 | 2016-11-04 | ||
KR1020160146850A KR101935636B1 (en) | 2016-11-04 | 2016-11-04 | A method for preparation of (S)-N1-(2-aminoethyl)-3-(4-alkoxyphenyl)propane-1,2-diamine trihydrocholoride |
PCT/KR2017/012389 WO2018084625A1 (en) | 2016-11-04 | 2017-11-03 | Method for preparation of (s)-n1-(2-aminoethyl)-3-(4-alkoxyphenyl)propane-1,2-diamine trihydrochloride |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019534299A true JP2019534299A (en) | 2019-11-28 |
JP6816274B2 JP6816274B2 (en) | 2021-01-20 |
Family
ID=62076303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019523878A Active JP6816274B2 (en) | 2016-11-04 | 2017-11-03 | (S) Method for producing -N1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride |
Country Status (5)
Country | Link |
---|---|
US (1) | US10501403B2 (en) |
EP (1) | EP3535237A4 (en) |
JP (1) | JP6816274B2 (en) |
KR (1) | KR101935636B1 (en) |
WO (1) | WO2018084625A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109232199B (en) * | 2018-09-13 | 2021-11-30 | 南京红杉生物科技有限公司 | Synthesis method of 1-chloro-2- (4-ethoxybenzyl) -4-iodobenzene |
CN109232279B (en) * | 2018-10-24 | 2021-03-30 | 上海司太立制药有限公司 | Purification method of gadoxetic acid disodium intermediate |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008526993A (en) * | 2005-01-13 | 2008-07-24 | ブリストル−マイヤーズ スクイブ カンパニー | Glucocorticoid receptor, AP-1 and / or substituted heteroarylamide modulators of NF-κB activity and uses thereof |
WO2009105668A1 (en) * | 2008-02-20 | 2009-08-27 | President And Fellows Of Harvard College | Bicyclic guanidines, metal complexes thereof and their use in vapor deposition |
JP2011512321A (en) * | 2007-10-05 | 2011-04-21 | アキュセラ, インコーポレイテッド | Alkoxy compounds for disease treatment |
JP2012522044A (en) * | 2009-03-30 | 2012-09-20 | ドン ア ファーマシューティカル カンパニー リミテッド | Improved process for the preparation of dipeptidyl peptidase-IV inhibitors and intermediates |
CN103896788A (en) * | 2012-12-27 | 2014-07-02 | 齐鲁制药有限公司 | Preparation method of S-1-(4-ethyoxylbenzyl)-3-azapentane-1,5-diaminetrihydrochloride |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100534976C (en) * | 2007-01-16 | 2009-09-02 | 江苏省原子医学研究所 | S-1-(4-ethoxybenzyl)-3-azapentane-1,5 diamine preparation method |
CN104761461A (en) | 2014-09-09 | 2015-07-08 | 山东富创医药科技有限公司 | Preparation method of novel gadoxetate disodium intermediate |
CN105001118A (en) * | 2015-07-20 | 2015-10-28 | 湖南华腾制药有限公司 | Method for preparing iodine-containing azido compound |
WO2017208258A1 (en) * | 2016-05-30 | 2017-12-07 | Biophore India Pharmaceuticals Pvt. Ltd. | Novel process for the preparation of gadolinium complex of (4s)-4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9- triazaundecanedioic acid disodium (gadoxetate disodium) |
-
2016
- 2016-11-04 KR KR1020160146850A patent/KR101935636B1/en active IP Right Grant
-
2017
- 2017-11-03 JP JP2019523878A patent/JP6816274B2/en active Active
- 2017-11-03 WO PCT/KR2017/012389 patent/WO2018084625A1/en unknown
- 2017-11-03 US US16/347,514 patent/US10501403B2/en active Active
- 2017-11-03 EP EP17867464.4A patent/EP3535237A4/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008526993A (en) * | 2005-01-13 | 2008-07-24 | ブリストル−マイヤーズ スクイブ カンパニー | Glucocorticoid receptor, AP-1 and / or substituted heteroarylamide modulators of NF-κB activity and uses thereof |
JP2011512321A (en) * | 2007-10-05 | 2011-04-21 | アキュセラ, インコーポレイテッド | Alkoxy compounds for disease treatment |
WO2009105668A1 (en) * | 2008-02-20 | 2009-08-27 | President And Fellows Of Harvard College | Bicyclic guanidines, metal complexes thereof and their use in vapor deposition |
JP2012522044A (en) * | 2009-03-30 | 2012-09-20 | ドン ア ファーマシューティカル カンパニー リミテッド | Improved process for the preparation of dipeptidyl peptidase-IV inhibitors and intermediates |
CN103896788A (en) * | 2012-12-27 | 2014-07-02 | 齐鲁制药有限公司 | Preparation method of S-1-(4-ethyoxylbenzyl)-3-azapentane-1,5-diaminetrihydrochloride |
Non-Patent Citations (1)
Title |
---|
ORGANIC LETTERS, vol. 8(15), JPN6020020661, 2006, pages 3371 - 3374, ISSN: 0004390440 * |
Also Published As
Publication number | Publication date |
---|---|
JP6816274B2 (en) | 2021-01-20 |
EP3535237A4 (en) | 2020-05-27 |
KR20180050471A (en) | 2018-05-15 |
US20190284126A1 (en) | 2019-09-19 |
WO2018084625A1 (en) | 2018-05-11 |
EP3535237A1 (en) | 2019-09-11 |
KR101935636B1 (en) | 2019-01-07 |
US10501403B2 (en) | 2019-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI440635B (en) | Process for the manufacture of an intermediate in the synthesis of dabigatran etexilate | |
KR101456438B1 (en) | Methods of synthesizing and isolating n-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same | |
US10065933B2 (en) | Method for preparing gadobutrol | |
JP2017088632A (en) | Compounds useful in the synthesis of benzamide compounds | |
JP2016145214A (en) | Method of synthesis of ferroquine by convergent reductive amination | |
CN112209938B (en) | Preparation method and intermediate of 2-indoline spirocyclic ketone compound | |
JP6816274B2 (en) | (S) Method for producing -N1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride | |
KR100674522B1 (en) | Process for Preparation of Spirofluorenols | |
KR101427221B1 (en) | Proces for purifying fluvoxamine free base and process for preparing high purity fluvoxamine maleate using the same | |
KR101520187B1 (en) | A method for preparation of an intermediate of iopromide | |
CN113072514A (en) | Preparation method of cycleanine and intermediate thereof | |
JP5279449B2 (en) | Process for producing 5- {4- [2- (5-ethyl-2-pyridyl) ethoxy] benzyl} -2,4-thiazolidinedione hydrochloride | |
KR101974388B1 (en) | Alkyl diethylene triamine derivatives and a process of the preparation thereof | |
KR102559870B1 (en) | Method for preparing carbamate compound | |
KR20180050091A (en) | A method for preparation of (S)-N1-(2-aminoethyl)-3-(4-alkoxyphenyl)propane-1,2-diamine trihydrocholoride | |
CN110418797B (en) | Method for preparing ketolide compound | |
KR101085170B1 (en) | Method of Preparing S-Rivastigmine | |
WO2023100110A1 (en) | Process for preparing brivaracetam | |
CN117603094A (en) | Synthesis method of amino-protected 2-aminomethyl olefine acid derivative | |
KR100929414B1 (en) | Process for the preparation of thromium chloride | |
CN117677617A (en) | Preparation method of hepatitis B virus nucleocapsid inhibitor | |
JPH0525111A (en) | Production of aliphatic amide or its salt | |
CN111848423A (en) | Preparation method of tert-butyl 3-oxocyclobutylcarbamate | |
JPH07285921A (en) | Production of 2-amino-n-(beta-hydroxyphenethyl)acetamide derivative | |
JPH06102644B2 (en) | Multi-coordinated aminotroponimine derivative and method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190710 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200423 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200616 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200916 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20201124 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20201223 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6816274 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |